News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Demetri George
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Demetri George (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| Demetri George (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 18,900 options to buy
@ $15.33, valued at
$289.7k
|
|
| 01/14/2020 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 568 shares
@ $85, valued at
$48.3k
|
|
| 01/09/2020 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,705 shares
@ $80.59, valued at
$137.4k
|
|
| 07/15/2019 |
4
| Demetri George (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 37,800 options to buy
@ $10.15, valued at
$383.7k
|
|
| 07/15/2019 |
3
| Demetri George (Director) has filed a Form 3 on Translate Bio, Inc. |
| 06/20/2019 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 4,875 options to buy
@ $96.77, valued at
$471.8k
Granted 1,312 restricted stock units
@ $0 |
|
| 06/19/2019 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 568 shares
@ $96.99, valued at
$55.1k
Sold 568 shares
@ $100, valued at
$56.8k
|
|
| 06/17/2019 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 568 shares
@ $90, valued at
$51.1k
|
|
| 06/25/2018 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 7,500 options to buy
@ $69.79, valued at
$523.4k
|
|
| 06/15/2018 |
4
| Demetri George (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Granted 7,000 options to buy
@ $9.67, valued at
$67.7k
|
|
| 03/21/2018 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,700 shares
@ $100.88, valued at
$171.5k
Sold 2,592 shares
@ $100.04, valued at
$259.3k
Sold 1,200 shares
@ $99.06, valued at
$118.9k
|
|
| 03/01/2018 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 200 shares
@ $90.68, valued at
$18.1k
Sold 200 shares
@ $89.48, valued at
$17.9k
Sold 3,085 shares
@ $88.45, valued at
$272.9k
Sold 2,765 shares
@ $87.85, valued at
$242.9k
|
|
| 12/15/2017 |
4
| Demetri George (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Granted 4,890 options to buy
@ $10.18, valued at
$49.8k
|
|
| 12/01/2017 |
3
| Demetri George (Director) has filed a Form 3 on MERRIMACK PHARMACEUTICALS INC |
| 06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2016 |
4
| Demetri George (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 10,909 options to buy
@ $19.53, valued at
$213.1k
|
|
|
|